The risk of placental abruption when using prostaglandins for cervical ripening in women with preeclampsia: comparing misoprostol versus dinoprostone.

MLA

Martinez de Tejada, Begoña, et al. “The Risk of Placental Abruption When Using Prostaglandins for Cervical Ripening in Women with Preeclampsia: Comparing Misoprostol versus Dinoprostone.” The Journal of Maternal-Fetal & Neonatal Medicine : The Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, vol. 23, no. 9, Sept. 2010, pp. 988–93. EBSCOhost, https://doi.org/10.3109/14767050903443475.

APA

Martinez de Tejada, B., Martillotti, G., Lapaire, O., Hoesli, I., & Irion, O. (2010). The risk of placental abruption when using prostaglandins for cervical ripening in women with preeclampsia: comparing misoprostol versus dinoprostone. The Journal of Maternal-Fetal & Neonatal Medicine : The Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 23(9), 988–993. https://doi.org/10.3109/14767050903443475

Chicago

Martinez de Tejada, Begoña, Gabriella Martillotti, Olav Lapaire, Irene Hoesli, and Olivier Irion. 2010. “The Risk of Placental Abruption When Using Prostaglandins for Cervical Ripening in Women with Preeclampsia: Comparing Misoprostol versus Dinoprostone.” The Journal of Maternal-Fetal & Neonatal Medicine : The Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 23 (9): 988–93. doi:10.3109/14767050903443475.